tiprankstipranks
Matinas BioPharma (MTNB)
XASE:MTNB
US Market
MTNB
Matinas BioPharma
RESEARCH TOOLSreports

Matinas BioPharma (MTNB) Income Statement

1,537 Followers

Matinas BioPharma Income Statement

Last quarter (Q4 2025), Matinas BioPharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Matinas BioPharma's net income was $-1.91M. See Matinas BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 1.10M$ 3.19M$ 33.00K
Gross Profit
$ 0.00$ 0.00$ 1.10M$ -13.49M$ -14.55M
Operating Expenses
$ 6.96M$ 24.59M$ 24.86M$ 11.10M$ 10.19M
Depreciation and Amortization
$ 456.00K$ 972.00K$ 941.00K$ 356.00K$ 280.00K
EBITDA
$ -6.50M$ -19.19M$ -22.82M$ -24.23M$ -24.45M
Operating Income
$ -6.96M$ -24.59M$ -23.77M$ -24.59M$ -24.73M
Other Income/Expenses
$ -3.38M$ 262.00K$ 824.00K$ 3.59M$ 1.45M
Pretax Income
$ -10.35M$ -24.33M$ -22.94M$ -21.00M$ -23.28M
Net Income
$ -10.35M$ -24.25M$ -22.94M$ -21.00M$ -23.28M
Per Share Metrics
Basic EPS
$ -2.00$ -4.98$ -5.28$ -3.00$ -5.04
Diluted EPS
$ -2.00$ -4.98$ -5.28$ -3.00$ -5.04
Weighted Average Shares Outstanding
 5.47M 4.87M 4.35M 4.34M 4.20M
Weighted Average Shares Outstanding (Diluted)
 5.47M 4.87M 4.35M 4.34M 4.20M
Currency in USD

Matinas BioPharma Earnings and Revenue History